pembrolizumab,ramucirumab
eli lilly,merck
['lung', 'lcsm,(-blcsm)', 'ramucirumab', 'east energy', 'pembro']
pembrolizumab and ramucirumab neoadjuvant therapy for pd-l1-positive stage ib-iiia lung cancer (east energy). mpr 50%, cpr 25% activity shown in both sqcc and nonsq histology. #asco23 #lcsm 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm